Nostalgia for an Age Yet to Come: Alienation, Neo-Emotions, and Radical Politics in Contemporary Capitalism
Emotion Review · 2026-07 · 18 (3) · 132-143
DOI: 10.1177/17540739261441747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emotion Review, online erschienen am 23.04.2026. Verfasst von Ian Burkitt. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This article analyzes the emotions of alienation, estrangement, and nostalgia, and how they are central to the production of neo-emotions in contemporary society. Alienation is a product of the macro-social context of capitalist societies and contemporary neo-emotions are a response to this, addressing the current misalignment between people, their emotional experiences, and their dynamic environment. I consider how alienation affects those on the left of politics, including those involved in radical activism, and how neo-emotions are the creative practices that forge new identities and collectives for active resistance. Those struggling to create non-alienated societies always experienced conflicting emotions, like optimism and pessimism, hope and despair, but these can be synthesized into positive neo-emotions such as progressive nostalgia and radical hope.
Zitieren
APA
Burkitt, I. (2026). Nostalgia for an Age Yet to Come: Alienation, Neo-Emotions, and Radical Politics in Contemporary Capitalism. Emotion Review, 18(3), 132-143. https://doi.org/10.1177/17540739261441747
Vancouver
Burkitt I. Nostalgia for an Age Yet to Come: Alienation, Neo-Emotions, and Radical Politics in Contemporary Capitalism. Emotion Review. 2026;18(3):132-143. doi:10.1177/17540739261441747
BibTeX
@article{Burkitt2026,
author = {Burkitt, Ian},
title = {Nostalgia for an Age Yet to Come: Alienation, Neo-Emotions, and Radical Politics in Contemporary Capitalism},
journal = {Emotion Review},
year = {2026},
volume = {18},
number = {3},
pages = {132--143},
doi = {10.1177/17540739261441747}
}
EUVIMED